Epidemiological Studies of HPV Infection and Vaccination
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Epidemiology".
Deadline for manuscript submissions: closed (10 September 2021) | Viewed by 8207
Special Issue Editor
Special Issue Information
Dear Colleagues,
The effectiveness of the HPV vaccine for precancerous lesions of cervical cancer has been demonstrated in many epidemiological studies, and the effect on cervical invasive cancer was also reported for the first time in the world from Sweden last October. It has been reported that persistent HPV infection increases the carcinogenic risk of vaginal/vulvar cancer, penile cancer, anal cancer, and oropharyngeal cancer; however, there are still few reports on the course of HPV infection and the efficacy of HPV vaccines at those sites. In addition, the epidemiologic profiles of type-specific HPV infection vary from region to region, and their epidemiological data are very important in predicting the efficacy of 9-valent vaccines. The understanding the profile of HPV infection will help develop new cancer screening methods. In this Special Issue, we will focus on HPV infection not only in the cervix but also in other parts of the body, and would like to provide a deeper discussion on the effectiveness of HPV vaccine.
Dr. Masayuki Sekine
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- HPV infection
- HPV vaccine
- epidemiological study
- HPV-related cancer
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
